1
/
of
1
Elsevier Health Sciences
Current Management of Serious Bacterial Infections Associated with Multi-Drug Resistance, An Issue of Infectious Disease Clinics of North America
Current Management of Serious Bacterial Infections Associated with Multi-Drug Resistance, An Issue of Infectious Disease Clinics of North America
💎 Earn 380 Points (£3.80) on this item.
ORDERED FOR YOU
We can order this item for you. Delivery usually takes about 4 to 6 weeks.
This item is not held in our immediate stock. We will order it for you after checkout.
Estimated delivery: About 4 to 6 weeks
Regular price
£76.10 GBP
Regular price
£85.99 GBP
Sale price
£76.10 GBP
Unit price
/
per
Taxes included.
Shipping calculated at checkout.
YOU SAVE £9.89
- Condition: Brand new
- UK Delivery times: Usually arrives within 2 - 3 working days
- UK Shipping: Fee starts at £3.89. Subject to product weight & dimension
Bulk ordering. Want 15 or more copies? Get a personalised quote and bigger discounts. Learn more about bulk orders.
Couldn't load pickup availability
- More about Current Management of Serious Bacterial Infections Associated with Multi-Drug Resistance, An Issue of Infectious Disease Clinics of North America
In this issue of Infectious Disease Clinics of North America, guest editor Dr. David L. Paterson brings his considerable expertise to the topic of Current Management of Serious Bacterial Infections Associated with Multi-Drug Resistance. Top experts provide current reviews that highlight innovative solutions to the treatment difficulties faced by clinicians when they encounter multi-resistant bacteria. Articles cover management of VRE infections; AMR in transplant recipients; rapid diagnostic strategies for antibiotic-resistant bacteria causing bloodstream infection; current management strategies for hypervirulent Klebsiella; current management of melioidosis; and more.
- Contains 16 relevant, practice-oriented topics including current management strategies for Pseudomonas aeruginosa; non-traditional approaches in the treatment of multiresistant gram-negative bacilli; current management strategies for Staphylococcus aureus bloodstream infections; an update on antimicrobial stewardship; and more
- Provides in-depth clinical reviews on current management of serious bacterial infections associated with multi-drug resistance, offering actionable insights for clinical practice
- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews
- Publication date: 24 February 2026
- Page count: 240
- Dimensions: Height 229 mm; Width 152 mm
- Publisher: Elsevier Health Sciences
- Format: Hardback
- ISBN-13: 9780443428814
UK and International shipping information
UK and International shipping information
We deliver throughout the United Kingdom and to 128 countries and territories worldwide, including the United States, Australia, Canada, Germany, Spain and France.
